Results 91 to 100 of about 205,002 (367)

Leiomyosarcoma of the inferior vena cava: a case report and review of the literature [PDF]

open access: yes, 2010
A 68-year-old white female presented with two years of progressively worsening dyspnea. Echocardiography revealed a large right atrial mass and partial obstruction of the inferior vena cava.
Birkbeck, James P   +7 more
core   +1 more source

Acute cardiovascular effects associated with the use of prescription medications: A Danish nationwide screening study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aim This study aims to conduct a hypothesis‐generating screening for acute cardiovascular effects of prescription medications. Methods This Danish nationwide screening study was conducted among incident cases of cardiovascular diseases, including myocardial infarction (MI), ischemic stroke (IS), heart failure (HF), venous thromboembolism (VTE),
Saad Hanif Abbasi   +4 more
wiley   +1 more source

Superior vena cava obstruction presenting with epistaxis, haemoptysis and gastro-intestinal haemorrhage in two men receiving haemodialysis with central venous catheters: two case reports [PDF]

open access: yes, 2009
Introduction Superior vena cava (SVC) obstruction secondary to central venous catheterization is an increasingly recognized complication. Case presentation We present two cases of superior vena cava obstruction secondary to indwelling central venous ...
AR Forauer   +8 more
core   +3 more sources

The accessory renal arteries: A systematic review with meta‐analysis

open access: yesClinical Anatomy, EarlyView.
Abstract The accessory renal arteries (ARAs) are a well‐described variant of the renal vasculature with clinical implications for radiologists, surgeons, and clinicians. The aim of the present systematic review with meta‐analysis was to estimate the pooled prevalence of ARAs, including their variant number, origin, and termination, and to highlight ...
George Triantafyllou   +6 more
wiley   +1 more source

On the extremal families for the Kruskal--Katona theorem [PDF]

open access: yesarXiv, 2023
In \cite[Serra, Vena, Extremal families for the Kruskal-Katona theorem]{sv21}, the authors have shown a characterization of the extremal families for the Kruskal-Katona Theorem. We further develop some of the arguments given in \cite{sv21} and give additional properties of these extremal families.
arxiv  

Anomalies of the inferior vena cava: a report of two cases and a short review of the literature [PDF]

open access: yes, 2010
The inferior vena cava, also known as the posterior vena cava, is the large vein that carries de-oxygenated blood from the lower half of the body into the right atrium of the heart.
Dimitrakopoulou, G.   +4 more
core   +1 more source

Novel Transthoracic Pulmonary Valve Implantation Using Self‐Expanding Salus Valve: A Prospective Study of Safety and Mid‐Term Outcomes

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Transcatheter pulmonary valve replacement (TPVR) has emerged as a valuable treatment for severe pulmonary regurgitation (PR). The Salus valve (Balance Medical Technology Co. Ltd., Beijing, China) represents a novel self‐expanding valve stent designed for deployment through a transthoracic approach with a small subxiphoid incision ...
Ziqin Zhou   +6 more
wiley   +1 more source

A multilayer interstitial fluid flow along vascular adventitia [PDF]

open access: yesarXiv, 2020
Objective: Interstitial fluid flow through vascular adventitia has been disclosed recently. However, its kinetic pattern was unclear. Methods and Results: We used histological and topographical identifications to observe ISF flow along venous vessels in rabbits.
arxiv  

Fatal blunt trauma with rare and undetected superior vena cava rupture: A case report and literature review [PDF]

open access: yes, 2017
Laceration of the superior vena cava is an uncommon clinical entity almost always related to penetrating trauma. Rarely, however, it may occur after blunt thoracic trauma.
Barranco, Rosario   +3 more
core   +1 more source

Effect of Cytochrome P450 3A Inhibition and Induction by Itraconazole and Rifampin on Tazemetostat Pharmacokinetics in Patients With Advanced Malignancies

open access: yesClinical Pharmacology in Drug Development, EarlyView.
Abstract This study (NCT04537715) investigated itraconazole (strong cytochrome P450 [CYP] 3A inhibitor) and rifampin (strong CYP3A inducer) on tazemetostat pharmacokinetics. In Part 1, patients received tazemetostat 400 mg orally on Days 1, 15, and 36, and 400 mg twice daily on Days 3‐14 and Days 21‐35.
Yingxue Chen   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy